BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Richardson SE, Karmali MA, Becker LE, Smith CR. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988;19:1102-8. [PMID: 3047052 DOI: 10.1016/s0046-8177(88)80093-5] [Cited by in Crossref: 230] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Álvarez RS, Jancic C, Garimano N, Sacerdoti F, Paton AW, Paton JC, Ibarra C, Amaral MM. Crosstalk between Human Microvascular Endothelial Cells and Tubular Epithelial Cells Modulates Pro-Inflammatory Responses Induced by Shiga Toxin Type 2 and Subtilase Cytotoxin. Toxins (Basel) 2019;11:E648. [PMID: 31703347 DOI: 10.3390/toxins11110648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang W, Bielaszewska M, Kunsmann L, Mellmann A, Bauwens A, Köck R, Kossow A, Anders A, Gatermann S, Karch H. Lability of the pAA Virulence Plasmid in Escherichia coli O104:H4: Implications for Virulence in Humans. PLoS One 2013;8:e66717. [PMID: 23805269 DOI: 10.1371/journal.pone.0066717] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
3 Zhao YL, Cen XB, Ito M, Yokoyama K, Takagi K, Kitaichi K, Nadai M, Ohta M, Takagi K, Hasegawa T. Shiga-like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats. Antimicrob Agents Chemother 2002;46:1522-8. [PMID: 11959591 DOI: 10.1128/AAC.46.5.1522-1528.2002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kanzelmeyer NK, Pape L, Chobanyan-Jürgens K, Tsikas D, Hartmann H, Fuchs AJ, Vaske B, Das AM, Haubitz M, Jordan J, Lücke T. L-arginine/NO pathway is altered in children with haemolytic-uraemic syndrome (HUS). Oxid Med Cell Longev 2014;2014:203512. [PMID: 24757496 DOI: 10.1155/2014/203512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
5 Acheson DW, Keusch GT. The shigella paradigm and colitis due to enterohaemorrhagic Escherichia coli. Gut 1994;35:872-4. [PMID: 8063211 DOI: 10.1136/gut.35.7.872] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
6 Baker DR, Moxley RA, Steele MB, Lejeune JT, Christopher-Hennings J, Chen DG, Hardwidge PR, Francis DH. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle. Appl Environ Microbiol 2007;73:7338-46. [PMID: 17890332 DOI: 10.1128/AEM.00755-07] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
7 Dean-Nystrom EA, Bosworth BT, Cray WC Jr, Moon HW. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun 1997;65:1842-8. [PMID: 9125570 DOI: 10.1128/iai.65.5.1842-1848.1997] [Cited by in Crossref: 134] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
8 Chang HJ, Kim HY, Choi JH, Choi HJ, Ko JS, Ha IS, Cheong HI, Choi Y, Kang HG. Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome. Korean J Pediatr 2014;57:96-9. [PMID: 24678335 DOI: 10.3345/kjp.2014.57.2.96] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Mayer CL, Leibowitz CS, Kurosawa S, Stearns-Kurosawa DJ. Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals. Toxins (Basel) 2012;4:1261-87. [PMID: 23202315 DOI: 10.3390/toxins4111261] [Cited by in Crossref: 86] [Cited by in F6Publishing: 68] [Article Influence: 8.6] [Reference Citation Analysis]
10 Boyd B, Tyrrell G, Maloney M, Gyles C, Brunton J, Lingwood C. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs. J Exp Med 1993;177:1745-53. [PMID: 8496689 DOI: 10.1084/jem.177.6.1745] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zotta E, Lago N, Ochoa F, Repetto HA, Ibarra C. Development of an experimental hemolytic uremic syndrome in rats. Pediatr Nephrol 2008;23:559-67. [PMID: 18253762 DOI: 10.1007/s00467-007-0727-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
12 Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang AC, Kosanke SD, Pysher TJ, Siegler RL. Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 1999;154:1285-99. [PMID: 10233866 DOI: 10.1016/S0002-9440(10)65380-1] [Cited by in Crossref: 98] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
13 Amaral MM, Sacerdoti F, Jancic C, Repetto HA, Paton AW, Paton JC, Ibarra C. Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells. PLoS One 2013;8:e70431. [PMID: 23936204 DOI: 10.1371/journal.pone.0070431] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
14 Rosen SA, Wexner SD, Woodhouse S, Colquhoun P, Weiss EG, Nogueras JJ, Efron J, Vernava A. Not All Inflammation in the Right Lower Quadrant is Appendicitis: A Case Report of Escherichia coli O157:H7 with a Review of the Literature. The American Surgeon 2005;71:532-6. [DOI: 10.1177/000313480507100619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Shubin AV, Demidyuk IV, Komissarov AA, Rafieva LM, Kostrov SV. Cytoplasmic vacuolization in cell death and survival. Oncotarget 2016;7:55863-89. [PMID: 27331412 DOI: 10.18632/oncotarget.10150] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 27.0] [Reference Citation Analysis]
16 Doulgere J, Otto B, Nassour M, Wolters-Eisfeld G, Rohde H, Magnus T, Wagener C, Streichert T. Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study. BMJ Open 2015;5:e005659. [PMID: 25757942 DOI: 10.1136/bmjopen-2014-005659] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
17 Bitzan MM, Wang Y, Lin J, Marsden PA. Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. J Clin Invest 1998;101:372-82. [PMID: 9435309 DOI: 10.1172/JCI522] [Cited by in Crossref: 62] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
18 Henrique IDM, Sacerdoti F, Ferreira RL, Henrique C, Amaral MM, Piazza RMF, Luz D. Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives. Front Cell Infect Microbiol 2022;12:825856. [DOI: 10.3389/fcimb.2022.825856] [Reference Citation Analysis]
19 Louise CB, Obrig TG. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 1992;60:1536-43. [PMID: 1548077 DOI: 10.1128/iai.60.4.1536-1543.1992] [Cited by in Crossref: 98] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
20 Hong JY, Jung JY, Kang YA, Bae YS, Kim YS, Kim SK, Chang J, Park MS. Delayed Hemolytic Uremic Syndrome Presenting as Diffuse Alveolar Hemorrhage. Korean J Crit Care Med 2014;29:43. [DOI: 10.4266/kjccm.2014.29.1.43] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998;11:450-79. [PMID: 9665978 DOI: 10.1128/CMR.11.3.450] [Cited by in Crossref: 936] [Cited by in F6Publishing: 357] [Article Influence: 39.0] [Reference Citation Analysis]
22 Winsor DK Jr, Ashkenazi S, Chiovetti R, Cleary TG. Adherence of enterohemorrhagic Escherichia coli strains to a human colonic epithelial cell line (T84). Infect Immun 1992;60:1613-7. [PMID: 1548083 DOI: 10.1128/iai.60.4.1613-1617.1992] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
23 Del Cogliano ME, Pinto A, Goldstein J, Zotta E, Ochoa F, Fernández-Brando RJ, Muniesa M, Ghiringhelli PD, Palermo MS, Bentancor LV. Relevance of Bacteriophage 933W in the Development of Hemolytic Uremic Syndrome (HUS). Front Microbiol 2018;9:3104. [PMID: 30619183 DOI: 10.3389/fmicb.2018.03104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Takahashi K, Funata N, Ikuta F, Sato S. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J Neuroinflammation 2008;5:11. [PMID: 18355415 DOI: 10.1186/1742-2094-5-11] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
25 Volokhina EB, Feitz WJC, Elders LM, van der Velden TJAM, van de Kar NCAJ, van den Heuvel LPWJ. Shiga Toxin Selectively Upregulates Expression of Syndecan-4 and Adhesion Molecule ICAM-1 in Human Glomerular Microvascular Endothelium. Toxins (Basel) 2020;12:E435. [PMID: 32635212 DOI: 10.3390/toxins12070435] [Reference Citation Analysis]
26 Russo LM, Melton-Celsa AR, Smith MA, Smith MJ, O'Brien AD. Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10. Infect Immun 2014;82:1213-21. [PMID: 24379294 DOI: 10.1128/IAI.01264-13] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
27 Kennedy J, Simmonds L, Orme R, Doherty W. An unusual case of Escherichia coli O157:H7 infection with pseudomembranous colitis-like lesions associated with haemolytic-uraemic syndrome and neurological sequelae. BMJ Case Rep 2017;2017:bcr-2016-218586. [PMID: 28630239 DOI: 10.1136/bcr-2016-218586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Menge C. The Role of Escherichia coli Shiga Toxins in STEC Colonization of Cattle. Toxins (Basel) 2020;12:E607. [PMID: 32967277 DOI: 10.3390/toxins12090607] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Thorpe CM, Pulsifer AR, Osburne MS, Vanaja SK, Leong JM. Citrobacter rodentium(ϕStx2dact), a murine infection model for enterohemorrhagic Escherichia coli. Curr Opin Microbiol 2021;65:183-90. [PMID: 34929548 DOI: 10.1016/j.mib.2021.11.013] [Reference Citation Analysis]
30 Bitzan M, Klemt M, Steffens R, Müller-Wiefel DE. Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls. Infection 1993;21:140-5. [PMID: 8365810 DOI: 10.1007/BF01710530] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
31 Yamamoto ET, Mizuno M, Nishikawa K, Miyazawa S, Zhang L, Matsuo S, Natori Y. Shiga toxin 1 causes direct renal injury in rats. Infect Immun 2005;73:7099-106. [PMID: 16239503 DOI: 10.1128/IAI.73.11.7099-7106.2005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
32 Wolski VM, Soltyk AM, Brunton JL. Mouse toxicity and cytokine release by verotoxin 1 B subunit mutants. Infect Immun 2001;69:579-83. [PMID: 11119557 DOI: 10.1128/IAI.69.1.579-583.2001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
33 Gallo EG, Gianantonio CA. Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome. Pediatr Nephrol 1995;9:117-9. [PMID: 7742210 DOI: 10.1007/BF00858990] [Cited by in Crossref: 59] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
34 Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol 2013; 2(3): 56-76 [PMID: 24255888 DOI: 10.5527/wjn.v2.i3.56] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
35 Schmidt CE, Shringi S, Besser TE. Protozoan Predation of Escherichia coli O157:H7 Is Unaffected by the Carriage of Shiga Toxin-Encoding Bacteriophages. PLoS One 2016;11:e0147270. [PMID: 26824472 DOI: 10.1371/journal.pone.0147270] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
36 Burdet J, Sacerdoti F, Cella M, Franchi AM, Ibarra C. Role of TNF-α in the mechanisms responsible for preterm delivery induced by Stx2 in rats. Br J Pharmacol 2013;168:946-53. [PMID: 23043728 DOI: 10.1111/j.1476-5381.2012.02239.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
37 Biernbaum EN, Kudva IT. AB5 Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins. Toxins (Basel) 2022;14:62. [PMID: 35051039 DOI: 10.3390/toxins14010062] [Reference Citation Analysis]
38 Saito M, Mylvaganum M, Tam P, Novak A, Binnington B, Lingwood C. Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics. J Biol Chem 2012;287:16073-87. [PMID: 22418442 DOI: 10.1074/jbc.M111.318196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
39 Thorpe CM, Smith WE, Hurley BP, Acheson DW. Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect Immun 2001;69:6140-7. [PMID: 11553553 DOI: 10.1128/IAI.69.10.6140-6147.2001] [Cited by in Crossref: 116] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
40 Bauwens A, Betz J, Meisen I, Kemper B, Karch H, Müthing J. Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature. Cell Mol Life Sci 2013;70:425-57. [PMID: 22766973 DOI: 10.1007/s00018-012-1060-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
41 Hurley BP, Thorpe CM, Acheson DW. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect Immun 2001;69:6148-55. [PMID: 11553554 DOI: 10.1128/IAI.69.10.6148-6155.2001] [Cited by in Crossref: 115] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
42 Menge C. Molecular Biology of Escherichia Coli Shiga Toxins' Effects on Mammalian Cells. Toxins (Basel) 2020;12:E345. [PMID: 32456125 DOI: 10.3390/toxins12050345] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
43 Brigotti M. The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? Toxins (Basel) 2012;4:157-90. [PMID: 22741061 DOI: 10.3390/toxins4030157] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
44 Fiorito P, Burgos JM, Miyakawa MF, Rivas M, Chillemi G, Berkowski D, Zotta E, Silberstein C, Ibarra C. Effect of Shiga toxin 2 on water and ion transport in human colon in vitro. Dig Dis Sci 2000;45:480-6. [PMID: 10749321 DOI: 10.1023/a:1005480720832] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Isogai E, Isogai H, Kimura K, Hayashi S, Kubota T, Fujii N, Takeshi K. Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect Immun 1998;66:197-202. [PMID: 9423858 DOI: 10.1128/IAI.66.1.197-202.1998] [Cited by in Crossref: 64] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
46 Békássy ZD, Calderon Toledo C, Leoj G, Kristoffersson A, Leopold SR, Perez MT, Karpman D. Intestinal damage in enterohemorrhagic Escherichia coli infection. Pediatr Nephrol 2011;26:2059-71. [PMID: 20809220 DOI: 10.1007/s00467-010-1616-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
47 Crane JK, Broome JE, Lis A. Biological Activities of Uric Acid in Infection Due to Enteropathogenic and Shiga-Toxigenic Escherichia coli. Infect Immun 2016;84:976-88. [PMID: 26787720 DOI: 10.1128/IAI.01389-15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
48 Mayer CL, Parello CS, Lee BC, Itagaki K, Kurosawa S, Stearns-Kurosawa DJ. Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga Toxins and Host Damage-Associated Molecular Patterns. Front Immunol 2015;6:155. [PMID: 25904918 DOI: 10.3389/fimmu.2015.00155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
49 Barrett TJ, Potter ME, Wachsmuth IK. Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect Immun 1989;57:3434-7. [PMID: 2680974 DOI: 10.1128/iai.57.11.3434-3437.1989] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
50 Pruimboom-Brees IM, Morgan TW, Ackermann MR, Nystrom ED, Samuel JE, Cornick NA, Moon HW. Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc Natl Acad Sci U S A 2000;97:10325-9. [PMID: 10973498 DOI: 10.1073/pnas.190329997] [Cited by in Crossref: 124] [Cited by in F6Publishing: 113] [Article Influence: 5.6] [Reference Citation Analysis]
51 Álvarez RS, Sacerdoti F, Jancic C, Paton AW, Paton JC, Ibarra C, Amaral MM. Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions. PLoS One 2016;11:e0158180. [PMID: 27336788 DOI: 10.1371/journal.pone.0158180] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
52 Mohawk KL, Melton-Celsa AR, Zangari T, Carroll EE, O'Brien AD. Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora. Microb Pathog 2010;48:131-42. [PMID: 20096770 DOI: 10.1016/j.micpath.2010.01.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
53 Park JY, Jeong YJ, Park SK, Yoon SJ, Choi S, Jeong DG, Chung SW, Lee BJ, Kim JH, Tesh VL, Lee MS, Park YJ. Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells. Toxins (Basel) 2017;9:E319. [PMID: 29027919 DOI: 10.3390/toxins9100319] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
54 Kojima S, Yanagihara I, Kono G, Sugahara T, Nasu H, Kijima M, Hattori A, Kodama T, Nagayama KI, Honda T. mkp-1 encoding mitogen-activated protein kinase phosphatase 1, a verotoxin 1 responsive gene, detected by differential display reverse transcription-PCR in Caco-2 cells. Infect Immun 2000;68:2791-6. [PMID: 10768974 DOI: 10.1128/IAI.68.5.2791-2796.2000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
55 Lentz EK, Cherla RP, Jaspers V, Weeks BR, Tesh VL. Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage. Infect Immun 2010;78:3689-99. [PMID: 20605983 DOI: 10.1128/IAI.00616-10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
56 Catón B, Díaz de Otazu R, Aldamiz-Echebarria M, Viguri A. Haemolytic-uraemic syndrome with thrombotic microangiopathy of the retina following cytomegalovirus infection: postmortem findings. Postgrad Med J 1993;69:653-5. [PMID: 8234116 DOI: 10.1136/pgmj.69.814.653] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
57 Stein RA, Katz DE. Escherichia coli, cattle and the propagation of disease. FEMS Microbiol Lett 2017;364. [PMID: 28333229 DOI: 10.1093/femsle/fnx050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
58 Álvarez RS, Gómez FD, Zotta E, Paton AW, Paton JC, Ibarra C, Sacerdoti F, Amaral MM. Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome. Toxins (Basel) 2021;13:536. [PMID: 34437406 DOI: 10.3390/toxins13080536] [Reference Citation Analysis]
59 Bogdanović R, Cobeljić M, Marković M, Nikolić V, Ognjanović M, Sarjanović L, Makić D. Haemolytic-uraemic syndrome associated with Aeromonas hydrophila enterocolitis. Pediatr Nephrol 1991;5:293-5. [PMID: 1867983 DOI: 10.1007/BF00867480] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
60 Lee MS, Cherla RP, Tesh VL. Shiga toxins: intracellular trafficking to the ER leading to activation of host cell stress responses. Toxins (Basel) 2010;2:1515-35. [PMID: 22069648 DOI: 10.3390/toxins2061515] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
61 Korcheva V, Wong J, Corless C, Iordanov M, Magun B. Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome. Am J Pathol 2005;166:323-39. [PMID: 15632024 DOI: 10.1016/S0002-9440(10)62256-0] [Cited by in Crossref: 76] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
62 Guirro M, Piazza RM, de Souza RL, Guth BE. Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls. BMC Infect Dis 2014;14:320. [PMID: 24919599 DOI: 10.1186/1471-2334-14-320] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
63 Richardson SE, Rotman TA, Jay V, Smith CR, Becker LE, Petric M, Olivieri NF, Karmali MA. Experimental verocytotoxemia in rabbits. Infect Immun 1992;60:4154-67. [PMID: 1398926 DOI: 10.1128/iai.60.10.4154-4167.1992] [Cited by in Crossref: 102] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
64 Bunger JC, Melton-Celsa AR, Maynard EL, O'Brien AD. Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin. Toxins (Basel) 2015;7:2306-20. [PMID: 26110507 DOI: 10.3390/toxins7062306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
65 Bielaszewska M, Köck R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H, Mellmann A. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One 2007;2:e1024. [PMID: 17925872 DOI: 10.1371/journal.pone.0001024] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 7.5] [Reference Citation Analysis]
66 Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 2008;23:1749-60. [PMID: 18704506 DOI: 10.1007/s00467-008-0935-6] [Cited by in Crossref: 183] [Cited by in F6Publishing: 140] [Article Influence: 13.1] [Reference Citation Analysis]
67 Nayar DM, Vetrivel S, Mcelroy J, Pai P, Koerner RJ. Toxic megacolon complicating Escherichia coli O157 infection. Journal of Infection 2006;52:e103-6. [DOI: 10.1016/j.jinf.2005.07.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
68 Bielaszewska M, Sinha B, Kuczius T, Karch H. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect Immun 2005;73:552-62. [PMID: 15618195 DOI: 10.1128/IAI.73.1.552-562.2005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
69 Lentz EK, Leyva-Illades D, Lee MS, Cherla RP, Tesh VL. Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2. Infect Immun 2011;79:3527-40. [PMID: 21708996 DOI: 10.1128/IAI.05139-11] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
70 Obrig TG. Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) 2010;2:2769-94. [PMID: 21297888 DOI: 10.3390/toxins2122769] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
71 Cimolai N. The Canadian contribution to the science of verotoxigenic Escherichia coli and associated illnesses: the early years. Can J Microbiol 2013;59:709-15. [DOI: 10.1139/cjm-2013-0644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Mallick EM, McBee ME, Vanguri VK, Melton-Celsa AR, Schlieper K, Karalius BJ, O'Brien AD, Butterton JR, Leong JM, Schauer DB. A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest 2012;122:4012-24. [PMID: 23041631 DOI: 10.1172/JCI62746] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]